Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.14B
Enterprise Value9.97B
P/E Ratio21.92
PEG Ratio-1.32
Price/Sales Ratio1.61
Price/Book Ratio1.55
Enterprise/Revenue1.52
Enterprise/EBITDA10.79

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue6.47B
Revenue/Share2.69
Gross Profit3.45B
EBITDA997.71M
Net Income474.36M
Diluted EPS0.19

Balance Sheet

Total Cash904.56M
Total Cash/Share0.36
Total Debt311.04M
Total Debt/Equity0.04
Current Ratio1.88
Book Value Per Share2.84

Price History

52-Week Change-1.82
52-Week High5.17
52-Week Low3.77
Moving Average 50 Days4.37
Moving Average 200 Days4.37

Statistics

Average Volume66.44M
Shares Outstanding2.54B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield3.48
Payout Ratio0.76
Last Split Factor3:2
Last Split DateJune 15, 2016
AD